Jyong Biotech (MENS) Company Sales Revenue

Jyong Biotech - graphic logo of issuer MENS

The goods sold by Jyong Biotech Ltd (MENS) demonstrate revenue dynamics where the value of 0.00 reflects this status. Jyong Biotech Ltd (MENS) maintains a strong position in niche markets due to inelastic demand for urological therapy. The brand synthesizes traditional medical expertise with modern scientific development standards. However, high research costs coupled with low revenues create a serious liquidity deficit and a dependence on loans.

MENS: Jyong Biotech Company Sales 06/18/2025 - 11/17/2026

Analytical breakdowns for Jyong Biotech Ltd

- market price and analyst price targets:
Summary company analysis:MENS - Jyong Biotech
Original product of Jyong Bio

Jyong Biotech Ltd (MENS) specialization in innovative urological drug delivery makes commercial revenue a key indicator of market adoption for its patented technologies. By analyzing the company's aggregate sales volume, an investor tracks the real-time cash inflow from product sales, which allows for the identification of asset overheating and the timely booking of profits within this high-risk security.

Competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Ligand Pharma LGND|Revenue and Sales Volume Amneal Corp AMRX|Perrigo Company PLC - Revenue and Sales Volume|ALVO: Company Revenue|liquidia.com (LQDA) - Company Revenue|GLPG (Galapagos) - Company Revenue|Company Sales ANIP|Company Sales Volume MNKD (Afrezza)|Revenue and Sales Volume AMPH|PCRX (Pacira BioSciences) - Company Sales Revenue|Revenue and Sales Volume SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Company Revenue|Aquestive Corp - Revenue and Sales Volume|scpharmaceuticals.com (SCPH) - Company Sales|TECX: Revenue and Sales Volume|Tonix Pharmaceuticals - Company Sales Revenue|Company Sales SXTC|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP